https://www.selleckchem.com/pr....oducts/atuzabrutinib
Functional capacity (FC) correlates with mortality in various cardiovascular diseases. The aim of this study was to examine whether cardiac pacemaker implantations improve the FC and affect the prognosis. We prospectively enrolled 621 de novo pacemaker recipients (age 76±9years, 50.7% male). The FC was assessed by metabolic equivalents (METs) during the implantation and periodically thereafter. The patients were a priori classified into poor FC (2 METs, n=4, moderate FC (2≤METs4, n=239), and good FC (≥4 METs, n=342). Thr
Like
Comment
Share
